Delivery Order SPE2DB22D9244-SPE2DB23FZS42
Award Date 7/12/23
Potential Completion Date 8/2/23
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DOD) awarded a $77,370 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The period of performance is from September 5, 2023 through September 26, 2023. As the DLA supports the logistical needs of the military services, this delivery order is likely providing a pharmaceutical product in support of DOD medical readiness programs over the three week period of...
- The Defense Logistics Agency, a combat support agency within the Department of Defense, awarded a $46,513.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois, and the period of performance is from September 29, 2023 through October 23, 2023. As the DLA supports military operations by providing food, fuel, repair parts and other supplies, this delivery order is likely...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $9,284.40 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the provision of 4562180535 XOLAIR 150 MG/ML SYRINGEML. The place of performance will be Park Ridge, Illinois, with work scheduled to be completed between September 12, 2023 and October 3, 2023. No major subcontractors or set aside designations were identified. This order is likely associated with DLA's...
- The Defense Logistics Agency (DOD) awarded a $11,605.50 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML" under contract number 4560195210. Performance will take place in Park Ridge, Illinois over a period of approximately three weeks from March 6th through March 27th, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports America's armed forces by providing supplies in...
- The Defense Logistics Agency, a component of the Department of Defense, awarded a $37,137.60 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The contract period runs from September 1, 2023 through September 25, 2023. No subcontractors or set aside designations were identified. The DLA supports military readiness by procuring and providing logistics support and supplies in support of various DOD...
- The Defense Logistics Agency awarded a $46,422 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/ml syringes. The contract has a period of performance from August 2nd to August 23rd, 2023, with all work to be conducted in Park Ridge, Illinois. DLA is the Department of Defense's combat logistics support agency, managing the global supply chain for the military's medical supplies. This delivery order falls under DLA's portfolio to ensure troops have access to...
- The Defense Logistics Agency awarded a $6,189.60 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois, with work scheduled to be completed between June 28, 2023 and July 20, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this delivery order was likely placed to supply the product to DOD customers and...
- The Defense Logistics Agency (DOD) awarded a $3,094.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is from July 27, 2023 through August 17, 2023. No major subcontractors or set aside designations were identified. The DLA supports military readiness by providing supplies to the armed forces, so this contract is likely for pharmaceutical...
- The Defense Logistics Agency awarded a $5,415.90 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The prime contractor will deliver the pharmaceutical products to a location in Park Ridge, Illinois by September 6, 2023 in support of DLA requirements. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA contract vehicle to supply pharmaceuticals and medical supplies for various Department...
- The Defense Logistics Agency (DOD) awarded a $18,568.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is from June 28, 2023 through July 20, 2023. As the DLA supports the logistical needs of the military services, this contract will likely deliver the pharmaceutical product to DOD medical treatment facilities and personnel within the...
- SPE2DB22D9244Indefinite Delivery Contract
- SPE2DB22D9244-SPE2DB23FZS42Delivery Order
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $11,605.50 firm fixed price delivery order contract to DMS Pharmaceutical Group Inc. for the purchase of 4561503521 XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The contract start date is July 12, 2023 and end date is August 2, 2023. No major subcontractors or set aside designations were identified. This delivery order was likely awarded against one of DLA's pharmaceutical supply chain management prime vendor contracts to support the medical treatment needs of DOD personnel.
Generated 12/23/23, 5:30 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 7/12/23 |